Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Down the Stairs Dystonia-A Novel Task-Specific Focal Isolated Syndrome.
Menon S, Muglan JA, Shimon L, Stewart D, Snow B, Hayes M, Fung VSC, Jog MS. Menon S, et al. Among authors: jog ms. Mov Disord Clin Pract. 2016 Jun 6;4(1):121-124. doi: 10.1002/mdc3.12371. eCollection 2017 Jan-Feb. Mov Disord Clin Pract. 2016. PMID: 30713957 Free PMC article.
Tourette-Like Syndrome in a Patient with RBFOX1 Deletion.
Murgai AA, Kumar N, Jog MS. Murgai AA, et al. Mov Disord Clin Pract. 2017 Oct 20;5(1):86-88. doi: 10.1002/mdc3.12549. eCollection 2018 Jan-Feb. Mov Disord Clin Pract. 2017. PMID: 30746397 Free PMC article. No abstract available.
Iron Chelation in Movement Disorders: Logical or Ironical.
Kulshreshtha D, Ganguly J, Jog M. Kulshreshtha D, et al. Among authors: jog m. Can J Neurol Sci. 2021 Nov;48(6):752-759. doi: 10.1017/cjn.2020.279. Epub 2021 Jan 5. Can J Neurol Sci. 2021. PMID: 33397531 Review.
Manganese and Movement Disorders: A Review.
Kulshreshtha D, Ganguly J, Jog M. Kulshreshtha D, et al. Among authors: jog m. J Mov Disord. 2021 May;14(2):93-102. doi: 10.14802/jmd.20123. Epub 2021 Apr 6. J Mov Disord. 2021. PMID: 33819420 Free PMC article.
Muscle Tone Physiology and Abnormalities.
Ganguly J, Kulshreshtha D, Almotiri M, Jog M. Ganguly J, et al. Among authors: jog m. Toxins (Basel). 2021 Apr 16;13(4):282. doi: 10.3390/toxins13040282. Toxins (Basel). 2021. PMID: 33923397 Free PMC article. Review.
Minipolymyoclonus: A Critical Appraisal.
Ganguly J, Chai JR, Jog M. Ganguly J, et al. Among authors: jog m. J Mov Disord. 2021 May;14(2):114-118. doi: 10.14802/jmd.20166. Epub 2021 May 26. J Mov Disord. 2021. PMID: 34062647 Free PMC article. No abstract available.
Mercury and Movement Disorders: The Toxic Legacy Continues.
Ganguly J, Kulshreshtha D, Jog M. Ganguly J, et al. Among authors: jog m. Can J Neurol Sci. 2022 Jul;49(4):493-501. doi: 10.1017/cjn.2021.146. Epub 2021 Jun 24. Can J Neurol Sci. 2022. PMID: 34346303 Review.
Expanding the Clinical Spectrum of RFC1 Gene Mutations.
Kulshreshtha D, Ganguly J, Jog M. Kulshreshtha D, et al. Among authors: jog m. J Mov Disord. 2022 May;15(2):167-170. doi: 10.14802/jmd.21117. Epub 2022 Mar 22. J Mov Disord. 2022. PMID: 35306791 Free PMC article.
Effect of Levodopa on Speech Dysfluency in Parkinson's Disease.
Im H, Adams S, Abeyesekera A, Pieterman M, Gilmore G, Jog M. Im H, et al. Among authors: jog m. Mov Disord Clin Pract. 2018 Dec 30;6(2):150-154. doi: 10.1002/mdc3.12714. eCollection 2019 Feb. Mov Disord Clin Pract. 2018. PMID: 30838314 Free PMC article.
Parkinson's Disease, NOTCH3 Genetic Variants, and White Matter Hyperintensities.
Ramirez J, Dilliott AA, Binns MA, Breen DP, Evans EC, Beaton D, McLaughlin PM, Kwan D, Holmes MF, Ozzoude M, Scott CJM, Strother SC, Symons S, Swartz RH, Grimes D, Jog M, Masellis M, Black SE, Joutel A, Marras C, Rogaeva E, Hegele RA, Lang AE; Ontario Neurodegenerative Disease Research Initiative Investigators. Ramirez J, et al. Among authors: jog m. Mov Disord. 2020 Nov;35(11):2090-2095. doi: 10.1002/mds.28171. Epub 2020 Jun 23. Mov Disord. 2020. PMID: 32573853
Small and Large Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease Patients.
Ramirez J, Berberian SA, Breen DP, Gao F, Ozzoude M, Adamo S, Scott CJM, Berezuk C, Yhap V, Mestre TA, Marras C, Tartaglia MC, Grimes D, Jog M, Kwan D, Tan B, Binns MA, Arnott SR, Bartha R, Symons S, Masellis M, Black SE, Lang AE; ONDRI Investigators. Ramirez J, et al. Among authors: jog m. Mov Disord. 2022 Jun;37(6):1304-1309. doi: 10.1002/mds.29010. Epub 2022 Apr 11. Mov Disord. 2022. PMID: 35403259
Iron - too much of a good thing.
Jog MS, Debicki DB. Jog MS, et al. Can J Neurol Sci. 2012 May;39(3):263-4. doi: 10.1017/s0317167100013354. Can J Neurol Sci. 2012. PMID: 22547502 No abstract available.
Botulinum Toxin Induced Atrophy: An Uncharted Territory.
Salari M, Sharma S, Jog MS. Salari M, et al. Among authors: jog ms. Toxins (Basel). 2018 Aug 2;10(8):313. doi: 10.3390/toxins10080313. Toxins (Basel). 2018. PMID: 30072597 Free PMC article. Review.
Stiff-person syndrome.
Jog MS, Lambert CD, Lang AE. Jog MS, et al. Can J Neurol Sci. 1992 Aug;19(3):383-8. Can J Neurol Sci. 1992. PMID: 1393849
Femoral neuropathy in renal transplantation.
Jog MS, Turley JE, Berry H. Jog MS, et al. Can J Neurol Sci. 1994 Feb;21(1):38-42. doi: 10.1017/s0317167100048745. Can J Neurol Sci. 1994. PMID: 8180903
Diagnosing Parkinson's disease: the patient perspective.
Gofton TE, Jog M. Gofton TE, et al. Among authors: jog m. Can J Neurol Sci. 2008 Sep;35(4):510-2. doi: 10.1017/s0317167100009227. Can J Neurol Sci. 2008. PMID: 18973073 No abstract available.
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS Jr, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators. McGarry A, et al. Neurology. 2017 Jan 10;88(2):152-159. doi: 10.1212/WNL.0000000000003478. Epub 2016 Dec 2. Neurology. 2017. PMID: 27913695 Free PMC article. Clinical Trial.
Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial.
Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH. Silveira CRA, et al. Among authors: jog m. BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3. BMC Neurol. 2019. PMID: 30738426 Free PMC article. Clinical Trial.
Bilingualism in Parkinson's disease: Relationship to cognition and quality of life.
Fishman KN, Roberts AC, Orange JB, Sunderland KM, Marras C, Tan B, Steeves T, Kwan D, Lang AE, Grimes D, Levine B, Masellis M, Binns MA, Jog M, Strother SC, Investigators O, McLaughlin PM, Troyer AK. Fishman KN, et al. Among authors: jog m. J Clin Exp Neuropsychol. 2021 Mar;43(2):199-212. doi: 10.1080/13803395.2021.1902946. Epub 2021 Apr 8. J Clin Exp Neuropsychol. 2021. PMID: 33827353
MRI-visible perivascular space volumes, sleep duration and daytime dysfunction in adults with cerebrovascular disease.
Ramirez J, Holmes MF, Berezuk C, Kwan D, Tan B, Beaton D, Scott CJM, Ozzoude M, Gao F, Yu D, Swardfager W, Lawrence-Dewar J, Dowlatshahi D, Saposnik G, Boulos MI, Murray BJ, Symons S, Bartha R, Black SE, Swartz RH; ONDRI Investigators; Lim A. Ramirez J, et al. Sleep Med. 2021 Jul;83:83-88. doi: 10.1016/j.sleep.2021.03.043. Epub 2021 Apr 19. Sleep Med. 2021. PMID: 33991894
Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses.
Dilliott AA, Sunderland KM, McLaughlin PM, Roberts AC, Evans EC, Abrahao A, Binns MA, Black SE, Borrie M, Casaubon LK, Dowlatshahi D, Finger E, Fischer CE, Frank A, Freedman M, Grimes D, Hassan A, Jog M, Kumar S, Kwan D, Lang AE, Mandzia J, Marras C, Masellis M, McIntyre AD, Pasternak S, Pollock BG, Rajji TK, Robinson JF, Rogaeva E, Sahlas DJ, Saposnik G, Sato C, Seitz D, Shoesmith C, Steeves T, Strother SC, Swartz RH, Tan B, Tang-Wai D, Tartaglia MC, Troyer AK, Turnbull J, Zinman L; ONDRI Investigators; Hegele RA. Dilliott AA, et al. Among authors: jog m. Neurobiol Aging. 2021 Sep;105:378.e1-378.e9. doi: 10.1016/j.neurobiolaging.2021.04.011. Epub 2021 Apr 24. Neurobiol Aging. 2021. PMID: 34039480
Contribution of rare variant associations to neurodegenerative disease presentation.
Dilliott AA, Abdelhady A, Sunderland KM, Farhan SMK, Abrahao A, Binns MA, Black SE, Borrie M, Casaubon LK, Dowlatshahi D, Finger E, Fischer CE, Frank A, Freedman M, Grimes D, Hassan A, Jog M, Kumar S, Kwan D, Lang AE, Mandzia J, Masellis M, McIntyre AD, Pasternak SH, Pollock BG, Rajji TK, Rogaeva E, Sahlas DJ, Saposnik G, Sato C, Seitz D, Shoesmith C, Steeves TDL, Swartz RH, Tan B, Tang-Wai DF, Tartaglia MC, Turnbull J, Zinman L; ONDRI Investigators; Hegele RA. Dilliott AA, et al. Among authors: jog m. NPJ Genom Med. 2021 Sep 28;6(1):80. doi: 10.1038/s41525-021-00243-3. NPJ Genom Med. 2021. PMID: 34584092 Free PMC article.
Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseases.
Ozzoude M, Varriano B, Beaton D, Ramirez J, Holmes MF, Scott CJM, Gao F, Sunderland KM, McLaughlin P, Rabin J, Goubran M, Kwan D, Roberts A, Bartha R, Symons S, Tan B, Swartz RH, Abrahao A, Saposnik G, Masellis M, Lang AE, Marras C, Zinman L, Shoesmith C, Borrie M, Fischer CE, Frank A, Freedman M, Montero-Odasso M, Kumar S, Pasternak S, Strother SC, Pollock BG, Rajji TK, Seitz D, Tang-Wai DF, Turnbull J, Dowlatshahi D, Hassan A, Casaubon L, Mandzia J, Sahlas D, Breen DP, Grimes D, Jog M, Steeves TDL, Arnott SR, Black SE, Finger E; ONDRI Investigators; Tartaglia MC. Ozzoude M, et al. Among authors: jog m. Geroscience. 2022 Jun;44(3):1575-1598. doi: 10.1007/s11357-022-00539-x. Epub 2022 Mar 16. Geroscience. 2022. PMID: 35294697 Free PMC article.
Targeted copy number variant identification across the neurodegenerative disease spectrum.
Dilliott AA, Zhang KK, Wang J, Abrahao A, Binns MA, Black SE, Borrie M, Dowlatshahi D, Finger E, Fischer CE, Frank A, Freedman M, Grimes D, Hassan A, Jog M, Kumar S, Lang AE, Mandzia J, Masellis M, Pasternak SH, Pollock BG, Rajji TK, Rogaeva E, Sahlas DJ, Saposnik G, Sato C, Seitz D, Shoesmith C, Steeves TDL, Swartz RH, Tan B, Tang-Wai DF, Tartaglia MC, Turnbull J, Zinman L; ONDRI Investigators; Hegele RA. Dilliott AA, et al. Among authors: jog m. Mol Genet Genomic Med. 2022 Aug;10(8):e1986. doi: 10.1002/mgg3.1986. Epub 2022 Jun 3. Mol Genet Genomic Med. 2022. PMID: 35666053 Free PMC article.
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort.
Sunderland KM, Beaton D, Arnott SR, Kleinstiver P, Kwan D, Lawrence-Dewar JM, Ramirez J, Tan B, Bartha R, Black SE, Borrie M, Brien D, Casaubon LK, Coe BC, Cornish B, Dilliott AA, Dowlatshahi D, Finger E, Fischer C, Frank A, Fraser J, Freedman M, Greenberg B, Grimes DA, Hassan A, Hatch W, Hegele RA, Hudson C, Jog M, Kumar S, Lang A, Levine B, Lou W, Mandzia J, Marras C, McIlroy W, Montero-Odasso M, Munoz DG, Munoz DP, Orange JB, Park DS, Pasternak SH, Pieruccini-Faria F, Rajji TK, Roberts AC, Robinson JF, Rogaeva E, Sahlas DJ, Saposnik G, Scott CJM, Seitz D, Shoesmith C, Steeves TDL, Strong MJ, Strother SC, Swartz RH, Symons S, Tang-Wai DF, Tartaglia MC, Troyer AK, Turnbull J, Zinman L, McLaughlin PM, Masellis M, Binns MA; ONDRI Investigators. Sunderland KM, et al. Among authors: jog m. Alzheimers Dement. 2023 Jan;19(1):226-243. doi: 10.1002/alz.12632. Epub 2022 Mar 30. Alzheimers Dement. 2023. PMID: 36318754
Hemiparkinsonism-somatic hemiatrophy syndrome.
Jenkins M, Mendonca D, Parrent A, Jog MS. Jenkins M, et al. Among authors: jog ms. Can J Neurol Sci. 2002 May;29(2):184-7. Can J Neurol Sci. 2002. PMID: 12035843
Memory perception and strategy use in Parkinson's disease.
Johnson AM, Pollard CC, Vernon PA, Tomes JL, Jog MS. Johnson AM, et al. Among authors: jog ms. Parkinsonism Relat Disord. 2005 Mar;11(2):111-5. doi: 10.1016/j.parkreldis.2004.06.005. Parkinsonism Relat Disord. 2005. PMID: 15734670
Is there seasonal variation in risk of Parkinson's disease?
Postuma RB, Wolfson C, Rajput A, Stoessl AJ, Martin WR, Suchowersky O, Chouinard S, Panisset M, Jog MS, Grimes DA, Marras C, Lang AE. Postuma RB, et al. Among authors: jog ms. Mov Disord. 2007 Jun 15;22(8):1097-101. doi: 10.1002/mds.21272. Mov Disord. 2007. PMID: 17486603
Canadian Guidelines on Parkinson's Disease.
Grimes D, Gordon J, Snelgrove B, Lim-Carter I, Fon E, Martin W, Wieler M, Suchowersky O, Rajput A, Lafontaine AL, Stoessl J, Moro E, Schoffer K, Miyasaki J, Hobson D, Mahmoudi M, Fox S, Postuma R, Kumar H, Jog M; Canadian Nourological Sciences Federation. Grimes D, et al. Among authors: jog m. Can J Neurol Sci. 2012 Jul;39(4 Suppl 4):S1-30. doi: 10.1017/s031716710001516x. Can J Neurol Sci. 2012. PMID: 23126020 No abstract available.
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
Parkinson Study Group QE3 Investigators; Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S… See abstract for full author list ➔ Parkinson Study Group QE3 Investigators, et al. Among authors: jog m. JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131. JAMA Neurol. 2014. PMID: 24664227 Free article. Clinical Trial.
Progression of brain atrophy in PSP and CBS over 6 months and 1 year.
Dutt S, Binney RJ, Heuer HW, Luong P, Attygalle S, Bhatt P, Marx GA, Elofson J, Tartaglia MC, Litvan I, McGinnis SM, Dickerson BC, Kornak J, Waltzman D, Voltarelli L, Schuff N, Rabinovici GD, Kramer JH, Jack CR Jr, Miller BL, Rosen HJ, Boxer AL; AL-108-231 investigators. Dutt S, et al. Neurology. 2016 Nov 8;87(19):2016-2025. doi: 10.1212/WNL.0000000000003305. Epub 2016 Oct 14. Neurology. 2016. PMID: 27742814 Free PMC article.
Movement Disorders Associated With Hemochromatosis.
Kumar N, Rizek P, Sadikovic B, Adams PC, Jog M. Kumar N, et al. Among authors: jog m. Can J Neurol Sci. 2016 Nov;43(6):801-808. doi: 10.1017/cjn.2016.286. Can J Neurol Sci. 2016. PMID: 27827297
Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.
Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ; TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators. Schobel SA, et al. Neurology. 2017 Dec 12;89(24):2495-2502. doi: 10.1212/WNL.0000000000004743. Epub 2017 Nov 15. Neurology. 2017. PMID: 29142089 Free PMC article.
Focal limb dystonia and tremor: Clinical update.
Murgai AA, Jog M. Murgai AA, et al. Among authors: jog m. Toxicon. 2020 Mar;176:10-14. doi: 10.1016/j.toxicon.2020.01.004. Epub 2020 Jan 13. Toxicon. 2020. PMID: 31965968
Sensory Trick in Painful Legs and Moving Toes Syndrome.
Kumar N, Murgai AA, Jog M. Kumar N, et al. Among authors: jog m. Neurol India. 2021 Sep-Oct;69(5):1436-1437. doi: 10.4103/0028-3886.329607. Neurol India. 2021. PMID: 34747836 Free article. No abstract available.
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.
Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, Roberson ED, Höglinger GU, Koestler M, Jack CR Jr, Van Deerlin V, Randolph C, Lobach IV, Heuer HW, Gozes I, Parker L, Whitaker S, Hirman J, Stewart AJ, Gold M, Morimoto BH; AL-108-231 Investigators. Boxer AL, et al. Lancet Neurol. 2014 Jul;13(7):676-85. doi: 10.1016/S1474-4422(14)70088-2. Epub 2014 May 27. Lancet Neurol. 2014. PMID: 24873720 Free PMC article. Clinical Trial.
Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
Rascol O, Tönges L, deVries T, Jaros M, Quartel A, Jacobs D; ALLAY-LID I and ALLAY-LID II study groups. Rascol O, et al. Parkinsonism Relat Disord. 2022 Mar;96:65-73. doi: 10.1016/j.parkreldis.2022.01.022. Epub 2022 Feb 8. Parkinsonism Relat Disord. 2022. PMID: 35227940 Free article. Clinical Trial.
A patient with tremor, part 1: making the diagnosis.
Kumar H, Jog M. Kumar H, et al. Among authors: jog m. CMAJ. 2011 Sep 20;183(13):1507-10. doi: 10.1503/cmaj.091782. Epub 2011 Aug 2. CMAJ. 2011. PMID: 21810957 Free PMC article. No abstract available.
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study.
Rashidi-Ranjbar N, Churchill NW, Black SE, Kumar S, Tartaglia MC, Freedman M, Lang A, Steeves TDL, Swartz RH, Saposnik G, Sahlas D, McLaughlin P, Symons S, Strother S, Pollock BG, Rajji TK, Ozzoude M, Tan B, Arnott SR, Bartha R, Borrie M, Masellis M, Pasternak SH, Frank A, Seitz D, Ismail Z, Tang-Wai DF, Casaubon LK, Mandzia J, Jog M, Scott CJM, Dowlatshahi D, Hassan A, Grimes D, Marras C, Zamyadi M, Munoz DG, Ramirez J, Berezuk C, Holmes M, Fischer CE, Schweizer TA. Rashidi-Ranjbar N, et al. Among authors: jog m. Int J Geriatr Psychiatry. 2024 Mar;39(3):e6074. doi: 10.1002/gps.6074. Int J Geriatr Psychiatry. 2024. PMID: 38491809
Variability of hand tremor in rest and in posture--a pilot study.
Rahimi F, Bee C, South A, Debicki D, Jog M. Rahimi F, et al. Among authors: jog m. Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:470-3. doi: 10.1109/IEMBS.2011.6090067. Annu Int Conf IEEE Eng Med Biol Soc. 2011. PMID: 22254350
A case of isolated sudden onset Dysphagia.
Rizek P, Barrett E, Jog M. Rizek P, et al. Among authors: jog m. Dysphagia. 2015 Apr;30(2):205-7. doi: 10.1007/s00455-015-9615-4. Epub 2015 Apr 12. Dysphagia. 2015. PMID: 25863451 No abstract available.
Wireless inertial measurement unit with GPS (WIMU-GPS)--wearable monitoring platform for ecological assessment of lifespace and mobility in aging and disease.
Boissy P, Brière S, Hamel M, Jog M, Speechley M, Karelis A, Frank J, Vincent C, Edwards R, Duval C; EMAP Group. Boissy P, et al. Among authors: jog m. Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:5815-9. doi: 10.1109/IEMBS.2011.6091439. Annu Int Conf IEEE Eng Med Biol Soc. 2011. PMID: 22255662
Visual velocity perception dysfunction in Parkinson's disease.
Bernardinis M, Atashzar SF, Jog MS, Patel RV. Bernardinis M, et al. Among authors: jog ms. Behav Brain Res. 2023 Aug 24;452:114490. doi: 10.1016/j.bbr.2023.114490. Epub 2023 May 10. Behav Brain Res. 2023. PMID: 37172741
Polyflex stent: is it radiopaque enough?
Jog M, Anderson DE, McGarry GW. Jog M, et al. J Laryngol Otol. 2003 Jan;117(1):83-4. doi: 10.1258/002221503321046748. J Laryngol Otol. 2003. PMID: 12590866
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
Brittain C, McCarthy A, Irizarry MC, McDermott D, Biglan K, Höglinger GU, Lorenzl S, Del Ser T, Boxer AL; AL-108-231 Study Group; PROPSPERA investigators; 4RNTI-1authors; Tau Restoration on PSP (TAUROS) Investigators. Brittain C, et al. Parkinsonism Relat Disord. 2019 Mar;60:138-145. doi: 10.1016/j.parkreldis.2018.08.025. Epub 2018 Sep 4. Parkinsonism Relat Disord. 2019. PMID: 30201421 Free PMC article. Clinical Trial.
278 results